Sensitive determination of BRAF copy number in clinical samples by pyrosequencing

Pilocytic astrocytoma is the most frequently occurring brain tumor during childhood. It is classified as grade I by the World Health Organization and may rarely evolve into higher-grade tumors. Frequent genetic abnormalities documented in astrocytomas in children are gains on chromosomal arm 7q. Dup...

Full description

Saved in:
Bibliographic Details
Main Author: El Maarri, Osman (author)
Other Authors: Setty, Prashanth (author), Gessi, Marco (author), Waha, Anke (author), Waha, Andreas (author), Torsten, Pietsch (author)
Format: article
Published: 2011
Online Access:http://hdl.handle.net/10725/6186
http://dx.doi.org/10.1097/PDM.0b013e3182143817
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://journals.lww.com/molecularpathology/Abstract/2011/09000/Sensitive_Determination_of_BRAF_Copy_Number_in.4.aspx
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513466155401216
author El Maarri, Osman
author2 Setty, Prashanth
Gessi, Marco
Waha, Anke
Waha, Andreas
Torsten, Pietsch
author2_role author
author
author
author
author
author_facet El Maarri, Osman
Setty, Prashanth
Gessi, Marco
Waha, Anke
Waha, Andreas
Torsten, Pietsch
author_role author
dc.creator.none.fl_str_mv El Maarri, Osman
Setty, Prashanth
Gessi, Marco
Waha, Anke
Waha, Andreas
Torsten, Pietsch
dc.date.none.fl_str_mv 2011
2017-09-14T09:08:23Z
2017-09-14T09:08:23Z
2017-09-14
dc.identifier.none.fl_str_mv 1533-4066
http://hdl.handle.net/10725/6186
http://dx.doi.org/10.1097/PDM.0b013e3182143817
Setty, P., Gessi, M., Waha, A., Hammes, J., El-Maarri, O., Pietsch, T., & Waha, A. (2011). Sensitive determination of BRAF copy number in clinical samples by pyrosequencing. Diagnostic Molecular Pathology, 20(3), 148-157.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://journals.lww.com/molecularpathology/Abstract/2011/09000/Sensitive_Determination_of_BRAF_Copy_Number_in.4.aspx
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Diagnostic Molecular Pathology
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Sensitive determination of BRAF copy number in clinical samples by pyrosequencing
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Pilocytic astrocytoma is the most frequently occurring brain tumor during childhood. It is classified as grade I by the World Health Organization and may rarely evolve into higher-grade tumors. Frequent genetic abnormalities documented in astrocytomas in children are gains on chromosomal arm 7q. Duplications at 7q34 lead to a fusion between genes KIAA1549 and BRAF resulting in constitutive activation of the BRAF kinase. The BRAF gene is located on chromosome 7q34 and a pseudogene has been identified on chromosome Xq13. We have developed a simple and sensitive pyrosequencing method for the determination of the BRAF copy number in clinical samples. The approach is based on the simultaneous amplification of a DNA fragment contained in exon 11 of BRAF and the respective pseudogene that is used as an internal control. Three different bases in the PCR product allow precise sequence assessment of products originating from the BRAF gene and the respective pseudogene and a calculation of gene copy numbers. After the calibration of the assay on 78 control DNA samples, 42 clinical PA samples were analyzed for variation in copy numbers by pyrosequencing and for fusion gene expression by reverse transcription-polymerase chain reaction. The results obtained from tumor DNA by the developed assay and the established reverse transcription-polymerase chain reaction assays show a high concordance. In summary, we have established a pyrosequencing-based assay allowing precise detection of BRAF copy numbers in DNA extracted from clinical samples.
eu_rights_str_mv openAccess
format article
id LAURepo_0d1b41a77ebc9741aed3978812be0d90
identifier_str_mv 1533-4066
Setty, P., Gessi, M., Waha, A., Hammes, J., El-Maarri, O., Pietsch, T., & Waha, A. (2011). Sensitive determination of BRAF copy number in clinical samples by pyrosequencing. Diagnostic Molecular Pathology, 20(3), 148-157.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/6186
publishDate 2011
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Sensitive determination of BRAF copy number in clinical samples by pyrosequencingEl Maarri, OsmanSetty, PrashanthGessi, MarcoWaha, AnkeWaha, AndreasTorsten, PietschPilocytic astrocytoma is the most frequently occurring brain tumor during childhood. It is classified as grade I by the World Health Organization and may rarely evolve into higher-grade tumors. Frequent genetic abnormalities documented in astrocytomas in children are gains on chromosomal arm 7q. Duplications at 7q34 lead to a fusion between genes KIAA1549 and BRAF resulting in constitutive activation of the BRAF kinase. The BRAF gene is located on chromosome 7q34 and a pseudogene has been identified on chromosome Xq13. We have developed a simple and sensitive pyrosequencing method for the determination of the BRAF copy number in clinical samples. The approach is based on the simultaneous amplification of a DNA fragment contained in exon 11 of BRAF and the respective pseudogene that is used as an internal control. Three different bases in the PCR product allow precise sequence assessment of products originating from the BRAF gene and the respective pseudogene and a calculation of gene copy numbers. After the calibration of the assay on 78 control DNA samples, 42 clinical PA samples were analyzed for variation in copy numbers by pyrosequencing and for fusion gene expression by reverse transcription-polymerase chain reaction. The results obtained from tumor DNA by the developed assay and the established reverse transcription-polymerase chain reaction assays show a high concordance. In summary, we have established a pyrosequencing-based assay allowing precise detection of BRAF copy numbers in DNA extracted from clinical samples.PublishedN/A2017-09-14T09:08:23Z2017-09-14T09:08:23Z20112017-09-14Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1533-4066http://hdl.handle.net/10725/6186http://dx.doi.org/10.1097/PDM.0b013e3182143817Setty, P., Gessi, M., Waha, A., Hammes, J., El-Maarri, O., Pietsch, T., & Waha, A. (2011). Sensitive determination of BRAF copy number in clinical samples by pyrosequencing. Diagnostic Molecular Pathology, 20(3), 148-157.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttp://journals.lww.com/molecularpathology/Abstract/2011/09000/Sensitive_Determination_of_BRAF_Copy_Number_in.4.aspxenDiagnostic Molecular Pathologyinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/61862021-03-19T10:00:49Z
spellingShingle Sensitive determination of BRAF copy number in clinical samples by pyrosequencing
El Maarri, Osman
status_str publishedVersion
title Sensitive determination of BRAF copy number in clinical samples by pyrosequencing
title_full Sensitive determination of BRAF copy number in clinical samples by pyrosequencing
title_fullStr Sensitive determination of BRAF copy number in clinical samples by pyrosequencing
title_full_unstemmed Sensitive determination of BRAF copy number in clinical samples by pyrosequencing
title_short Sensitive determination of BRAF copy number in clinical samples by pyrosequencing
title_sort Sensitive determination of BRAF copy number in clinical samples by pyrosequencing
url http://hdl.handle.net/10725/6186
http://dx.doi.org/10.1097/PDM.0b013e3182143817
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://journals.lww.com/molecularpathology/Abstract/2011/09000/Sensitive_Determination_of_BRAF_Copy_Number_in.4.aspx